Pentland AP - Search Results

1

Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.

Brouxhon S, Konger RL, VanBuskirk J, Sheu TJ, Ryan J, Erdle B, Almudevar A, Breyer RM, Scott G, Pentland AP. Brouxhon S, et al. Among authors: pentland ap. J Invest Dermatol. 2007 Feb;127(2):439-46. doi: 10.1038/sj.jid.5700547. Epub 2006 Sep 14. J Invest Dermatol. 2007. PMID: 16977324 Free article.

2

Pertussis toxin-sensitive secretory phospholipase A2 expression and motility in activated primary human keratinocytes.

Rys-Sikora KE, Pentland AP, Konger RL. Rys-Sikora KE, et al. Among authors: pentland ap. J Invest Dermatol. 2003 Jan;120(1):86-95. doi: 10.1046/j.1523-1747.2003.12001.x. J Invest Dermatol. 2003. PMID: 12535202 Free article.

3

sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism.

Scott GA, Jacobs SE, Pentland AP. Scott GA, et al. Among authors: pentland ap. J Invest Dermatol. 2006 Apr;126(4):855-61. doi: 10.1038/sj.jid.5700180. J Invest Dermatol. 2006. PMID: 16456529 Free article.

4

Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.

Brouxhon S, Kyrkanides S, O'Banion MK, Johnson R, Pearce DA, Centola GM, Miller JN, McGrath KH, Erdle B, Scott G, Schneider S, VanBuskirk J, Pentland AP. Brouxhon S, et al. Among authors: pentland ap. Cancer Res. 2007 Aug 15;67(16):7654-64. doi: 10.1158/0008-5472.CAN-06-4415. Cancer Res. 2007. PMID: 17699770

5

Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.

Pentland AP, Scott G, VanBuskirk J, Tanck C, LaRossa G, Brouxhon S. Pentland AP, et al. Cancer Res. 2004 Aug 15;64(16):5587-91. doi: 10.1158/0008-5472.CAN-04-1045. Cancer Res. 2004. PMID: 15313895

6

Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression.

Konger RL, Scott GA, Landt Y, Ladenson JH, Pentland AP. Konger RL, et al. Among authors: pentland ap. Am J Pathol. 2002 Dec;161(6):2065-78. doi: 10.1016/S0002-9440(10)64485-9. Am J Pathol. 2002. PMID: 12466123 Free PMC article.

7

Immunolocalization of low-affinity prostaglandin E receptors, EP and EP, in adult human epidermis.

Konger RL, Billings SD, Thompson AB, Morimiya A, Ladenson JH, Landt Y, Pentland AP, Badve S. Konger RL, et al. Among authors: pentland ap. J Invest Dermatol. 2005 May;124(5):965-70. doi: 10.1111/j.0022-202X.2005.23658.x. J Invest Dermatol. 2005. PMID: 15854037 Free article.

8

The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes.

Konger RL, Brouxhon S, Partillo S, VanBuskirk J, Pentland AP. Konger RL, et al. Among authors: pentland ap. Exp Dermatol. 2005 Dec;14(12):914-22. doi: 10.1111/j.1600-0625.2005.00381.x. Exp Dermatol. 2005. PMID: 16274459

9

Effects of continuous-wave (670-nm) red light on wound healing.

Erdle BJ, Brouxhon S, Kaplan M, Vanbuskirk J, Pentland AP. Erdle BJ, et al. Among authors: pentland ap. Dermatol Surg. 2008 Mar;34(3):320-5. doi: 10.1111/j.1524-4725.2007.34065.x. Epub 2007 Dec 20. Dermatol Surg. 2008. PMID: 18177400

10

Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.

Mantel A, Carpenter-Mendini AB, Vanbuskirk JB, De Benedetto A, Beck LA, Pentland AP. Mantel A, et al. Among authors: pentland ap. J Invest Dermatol. 2012 Apr;132(4):1103-10. doi: 10.1038/jid.2011.412. Epub 2011 Dec 15. J Invest Dermatol. 2012. PMID: 22170488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page